These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 175699)

  • 21. Complexing of reduced technetium and tin(II) by chelating phosphate compounds. II. In vitro stability of pyrophosphate and ethane-1, hydroxy-1, diphosphonate (EHDP) complexes.
    Schümichen C; Hohloch M; Hoffmann G
    Nuklearmedizin; 1979 May; 18(2):105-9. PubMed ID: 38437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic studies with 99mTc-HEDP in normal subjects and in patients with bone tumors.
    Citrin DL; Bessent RG; McGinley E; Gordon D
    J Nucl Med; 1975 Oct; 16(10):886-90. PubMed ID: 809552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A comparison of osteotropic radiopharmaceuticals. II. Plasma clearance of 18F and 99mTc-EHDP (author's transl)].
    Creutzig H
    Rofo; 1975 Oct; 123(4):313-8. PubMed ID: 129388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preliminary studies on (177)Lu-labeled sodium pyrophosphate (177Lu-PYP) as a potential bone-seeking radiopharmaceutical for bone pain palliation.
    Abbasi IA
    Nucl Med Biol; 2012 Aug; 39(6):763-9. PubMed ID: 22459337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of technetium-99m to plasma proteins: influence on the distribution of Tc-99m phosphate agents.
    Schümichen C; Koch K; Kraus A; Kuhlicke G; Weiler K; Wenn A; Hoffman G
    J Nucl Med; 1980 Nov; 21(11):1080-5. PubMed ID: 7431108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Technetium-99m-pyrophosphate: studies in vivo and in vitro.
    Kaye M; Silverton S; Rosenthall L
    J Nucl Med; 1975 Jan; 16(1):40-5. PubMed ID: 162947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical comparison of the kinetics of 99mTc pyrophosphate and 99mTc methylene diphosphonate (author's transl)].
    Casara D; Cimitan M; Zorat P; Calzavara F
    Radiol Med; 1979; 65(1-2):67-70. PubMed ID: 223200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparitive study on bone scintigrams with Tc-99m-labeled pyro-phosphate and F-18 (author's transl)].
    Arimizu N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1975 Feb; 35(2):101-4. PubMed ID: 167345
    [No Abstract]   [Full Text] [Related]  

  • 29. [Concentration of 99mTc-tin-phosphate complexes in soft tissues].
    Büll U; von Lieven H; Leisner B
    Nucl Med (Stuttg); 1975 Jun; 14(2):91-105. PubMed ID: 170592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative animal experiments concerning the distribution of 99mTc-pyrophosphate, 99mTc-diphosphonate and 85Sr (author's transl)].
    Büll U; Balser D; Frey KW
    Fortschr Geb Rontgenstr Nuklearmed; 1974 Apr; 120(4):481-8. PubMed ID: 4367024
    [No Abstract]   [Full Text] [Related]  

  • 31. A comparative study of three 99mTc-labeled phosphorus compounds and 18F-fluoride for skeletal imaging.
    Ackerhalt RE; Blau M; Bakshi S; Sondel JA
    J Nucl Med; 1974 Dec; 15(12):1153-7. PubMed ID: 4427143
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacologic and biokinetic data on the use of 99mTc-labeled phosphate compounds].
    Kriegel H
    Med Welt; 1977 Jan; 28(2):55-60. PubMed ID: 840011
    [No Abstract]   [Full Text] [Related]  

  • 33. Chemistry of 99mTc tracers. II. In vitro conversion of tagged HEDP and pyrophosphate (bone-seekers) into gluconate (renal agent). Effects of Ca and Fe (ii) on in vivo distribution.
    McRae J; Hambright P; Valk P; Bearden AJ
    J Nucl Med; 1976 Mar; 17(3):208-11. PubMed ID: 175138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical and biological evaluation of technetium (I) tricarbonyl complexes with EHIDA and DPD. 99m (I) complexes of EHIDA and DPD.
    Djokić DDj; Janković DLj; Stamenković LLj; Pirmettis I
    Nucl Med Rev Cent East Eur; 2004; 7(1):1-5. PubMed ID: 15318303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bone scintigraphy with 99m Tc polyphosphates (author's transl)].
    Oberson R
    Schweiz Rundsch Med Prax; 1974 Apr; 63(14):410-20. PubMed ID: 4363175
    [No Abstract]   [Full Text] [Related]  

  • 36. [Biokinetics of osteotropic radiopharmaceuticals in metabolic osteopathy--comparison of 47Ca and 99mTc-methylene-diphosphonate (MDP)].
    Knop J; Montz R
    Nuklearmedizin; 1983 Oct; 22(5):226-31. PubMed ID: 6228781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complexing of reduced technetium and tin (II) by chelating phosphate compounds. I. Chemical state of technetium.
    Schümichen C; Hohloch H; Schiller A; Pohle W; Hoffmann G
    Nuklearmedizin; 1979 May; 18(2):98-104. PubMed ID: 38438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood flow and bone uptake of 99mTc-labeled methylene diphosphonate.
    Riggs SA; Wood MB; Cooney WP; Kelly PJ
    J Orthop Res; 1984; 1(3):236-43. PubMed ID: 6237181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between bone uptake of 99mTc-pyrophosphate and hydroxyproline in blood and urine.
    Wiegmann T; Kirsh J; Rosenthall L; Kaye M
    J Nucl Med; 1976 Aug; 17(8):711-4. PubMed ID: 180269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative investigations of osteotropic isotopes. i animal experiments on the uptake of 18f, 85sr and 99mtc-ehdp (author's transl)].
    Creutzig H; Creutzig A; Gerdts KG; Greif E; Eckhardt W
    Rofo; 1975 Aug; 123(2):137-43. PubMed ID: 129373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.